Study saves B.C. PharmaCare costs and spurs further investment and research.
You are hereNews & Events
As few as five per cent of new cases of Multiple Sclerosis (MS) are diagnosed in children, but to better understand the disease, children may be our brightest source of hope. The Multiple Sclerosis Society of Canada and Multiple Sclerosis Scientific Research Foundation have announced new funding that will propel research into pediatric MS and the gut microbiome’s role in autoimmune and brain diseases.
New research finds that light therapy can treat non-seasonal depression and improve the overall wellbeing of people suffering from the disease.
Whether they’re conscious of it or not, many men struggle to identify and seek help for symptoms of depression. HeadsUpGuys – an online tool developed by Dr. John Ogrodniczuk and his team of clinicians, researchers, and mental health advocates – was designed to support men on their terms.
“Ultimately, I hope to help unleash the potential in students in healthcare-related programs to serve as change agents. Together we can usher in an era of unparalleled service delivery, while reducing errors, waste, and cost,” she says. “One day I will find my niche, or perhaps I shall create it.”
The Canadian Psychiatric Association (CPA) recognized exceptional psychiatrists, psychiatric residents and individuals for their contributions to the mental health of Canadians during their annual meeting in Vancouver on October 2.
A research study that hopes to improve the convenience and reduce the cost of a Health Canada-approved treatment for depression is underway, and the preliminary results are encouraging. Dr. Fidel Vila-Rodriguez, director of the Non-Invasive Neurostimulation Therapies (NINET) Lab at the Djavad Mowafaghian Centre for Brain Health, presented twice on his work at the Canadian Psychiatric Association Annual Meeting in Vancouver on October 1, 2015.
UBC’s investment of $1.5 million over three years in the Heart and Stroke Foundation Canadian Partnership for Stroke Recovery will accelerate the development of new therapies for people living with stroke disability.
The number of people living with multiple sclerosis (MS) in British Columbia has increased over the past 18 years, but the number of new MS cases each year has held stable, a new study has found.
Researchers hope the results of a new study will aid doctors in better supporting patients with multiple sclerosis. The study, published this week in Multiple Sclerosis Journal, tracked over 900 patients from four Canadian provinces over two years and found that during this time more than 50 percent were anxious, and over 35 percent were depressed.